Universal Health Services (UHS)
(Delayed Data from NYSE)
$178.98 USD
-3.26 (-1.79%)
Updated May 16, 2024 04:00 PM ET
After-Market: $178.91 -0.07 (-0.04%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$178.98 USD
-3.26 (-1.79%)
Updated May 16, 2024 04:00 PM ET
After-Market: $178.91 -0.07 (-0.04%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth B Momentum A VGM
Zacks News
Centene (CNC) Q2 Earnings Beat Estimates on Membership Growth
by Zacks Equity Research
Centene's (CNC) Q2 results benefit from growing premium and service revenues coupled with improving membership.
HCA Healthcare (HCA) Beats on Q2 Earnings, Ups 2023 EPS View
by Zacks Equity Research
HCA Healthcare's (HCA) Q2 results benefit from improving patient volumes and surgeries. However, rising expenses acted as a partial offset.
Teladoc Health (TDOC) Q2 Earnings Top Estimates on Lower Expenses
by Zacks Equity Research
Teladoc Health's (TDOC) Q2 results reflect improving access fees and other revenues coupled with lower expenses.
Universal Health (UHS) Q2 Earnings Beat, Boosts '23 EPS View
by Zacks Equity Research
Universal Health's (UHS) Q2 results indicate improved patient admissions and solid segmental performance. Management currently expects adjusted EPS within $9.85-$10.50 for 2023.
Universal Health Services (UHS) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
Although the revenue and EPS for Universal Health Services (UHS) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Universal Health Services (UHS) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Universal Health Services (UHS) delivered earnings and revenue surprises of 2.02% and 1.29%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
What's in the Cards for Universal Health (UHS) in Q2 Earnings?
by Zacks Equity Research
Universal Health's (UHS) Q2 results are likely to benefit from higher patient volumes at its acute care hospitals and behavioral health facilities, partly offset by increased physician expenses.
Despite Fast-paced Momentum, Universal Health Services (UHS) Is Still a Bargain Stock
by Zacks Equity Research
Universal Health Services (UHS) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Factors That Make Universal Health (UHS) an Attractive Bet Now
by Zacks Equity Research
Universal Health (UHS) remains well-poised for growth on the resumption of elective surgeries, a diversified treatment network and solid cash reserves.
UnitedHealth's (UNH) Suffering Continues: Should You Hold Tight?
by Zacks Equity Research
Each sub-segment of Optum, UnitedHealth's (UNH) health service business, is expected to continue delivering a solid performance, driving the overall segment's growth.
Zacks Industry Outlook Highlights HCA Healthcare, Universal Health, Tenet Healthcare and Community Health Systems
by Zacks Equity Research
HCA Healthcare, Universal Health, Tenet Healthcare and Community Health Systems have been highlighted in this Industry Outlook article.
4 Hospital Stocks in Focus Amid Improving Industry Trends
by Kaibalya Pravo Dey
Delayed elective procedures are boosting patient volumes for the Zacks Medical-Hospital industry players. HCA Healthcare (HCA), Universal Health (UHS), Tenet Healthcare (THC) and Community Health (CYH) are poised to gain from improving occupancy rates.
Why Universal Health Services (UHS) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Universal Health (UHS) Gains 3.7% as Pent-Up Surgeries Rise
by Zacks Equity Research
The pent-up demand for elective surgeries is expected to improve Universal Health's (UHS) patient admissions and patient days.
Company News for Jun 15, 2023
by Zacks Equity Research
Companies in The News Are: UNH, AMD, AMZN, UHS, DVN
Universal Health Services (UHS) Surges 3.7%: Is This an Indication of Further Gains?
by Zacks Equity Research
Universal Health Services (UHS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Investors Should Hold Universal Health (UHS) Now
by Zacks Equity Research
Universal Health (UHS) benefits from growing patient volumes, sound segmental performance and a solid capital position.
Universal Health Services (UHS) Down 10.8% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Universal Health Services (UHS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Tenet Healthcare's (THC) Q1 Earnings Beat, Shares Up 3.9%
by Zacks Equity Research
Tenet Healthcare's (THC) first-quarter 2023 results gain on increased patient volumes. Management presently expects adjusted EPS within $4.92-$6.09 in 2023, up from the prior view of $4.68-$5.85.
Universal Health (UHS) Q1 Earnings Beat on Higher Admissions
by Zacks Equity Research
Universal Health's (UHS) Q1 results reflect strong performance in acute care and behavioral health segments. Meanwhile, the elevated expense level partially offsets the positives.
Universal Health Services (UHS) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Universal Health Services (UHS) delivered earnings and revenue surprises of 8.84% and 1.30%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Universal Health (UHS) to Release Q1 Earnings: Factors to Note
by Zacks Equity Research
Universal Health's (UHS) Q1 results are likely to benefit from higher patient volumes and solid demand for behavioral healthcare services. However, increased labor costs might partly offset the results.
Universal Health Services (UHS) Reports Next Week: What to Know Ahead of the Release
by Zacks Equity Research
Universal Health Services (UHS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks Industry Outlook Highlights HCA Healthcare, Universal Health Services, Acadia Healthcare and Tenet Healthcare
by Zacks Equity Research
HCA Healthcare, Universal Health Services, Acadia Healthcare and Tenet Healthcare are part of the Zacks Industry Outlook article.